Manufacturing / In Vitro, In Vivo Diagnostic Substances
Intellia Therapeutics, Inc.
NTLA
$11.66
-$0.81 (-6.50%)
Price as of Nov 3, 2026 11:30 UTC
1.8 B
Market Cap (Small Cap)
59%
IV Rank
100.1%
Implied Volatility
Nov 04
Next Earnings
Technical Signals
as of Oct 30
Bearish
0 of 7
Trend
- Above 20-day average $12.11
- Above 50-day average $12.20
- Above 200-day average $12.53 · -0.5%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · 55d ago
- Momentum cross (20/50) Down · 73d ago
Volume
- Below-average volume 0.7x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.25
Bullish skew
Implied Volatility
100.1%
1% percentile
IV vs Realized
Options rich
30d HV 59.4%
Options Heat Map
Delta-risk grid for NTLA options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
2 buys
25 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Marantz Jing L. | Grant | 275,061 | $0 | +3.6% | |
| Oct 26, 2026 | Marantz Jing L. | Grant | 199,822 | $0 | +3.6% | |
| Oct 02, 2026 | Dube Michael P | Sell | 1,864 | $23,170 | -6.2% | |
| Aug 21, 2026 | LEONARD JOHN M | Sell | 2,785 | $36,205 | -10.3% | |
| Aug 20, 2026 | LEONARD JOHN M | Sell | 19,890 | $250,614 | -7.5% | |
| Jul 22, 2026 | Dulac Edward J III | Sell | 8,111 | $91,249 | +3.6% | |
| Jul 02, 2026 | Dulac Edward J III | Sell | 4,677 | $84,186 | -35.2% | |
| Jul 01, 2026 | Dube Michael P | Sell | 2,641 | $44,316 | -30.5% | |
| Jun 09, 2026 | GOODMAN JESSE | Grant | 9,200 | $0 | -9.5% | |
| Jun 09, 2026 | Keresty Georgia | Grant | 13,300 | $0 | -9.5% |
Politician Trades in NTLA
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Aug 25, 2023 | Thomas Richard Carper | D | Sale | $1K-$15K | — |
| May 22, 2023 | Thomas Richard Carper | D | Purchase | $1K-$15K | -71.9% |
| Feb 28, 2022 | Donald Sternoff Beyer | D | Sale | $21K | — |
| Oct 29, 2021 | Donald Sternoff Beyer | D | Sale | $1K-$15K | — |
| Sep 20, 2021 | Donald Sternoff Beyer | D | Sale | $1K-$15K | — |
| Jul 21, 2021 | Donald Sternoff Beyer | D | Sale | $1K-$15K | — |
| Jan 15, 2021 | Donald Sternoff Beyer | D | Sale | $1K-$15K | — |
| Nov 20, 2020 | Thomas Richard Carper | D | Purchase | $1K-$15K | -61.4% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 06, 2026 | Q2 2026 | -$0.82 | |||
| Aug 05, 2026 | Q2 2026 | -$0.82 | |||
| Jul 30, 2026 | Q2 2026 | -$0.82 | |||
| Mar 31, 2026 | Q1 2026 | -$0.93 | -$0.81 | +13.1% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.97 | -$0.83 | +14.8% | Beat |
| Sep 30, 2025 | Q3 2025 | -$1.02 | -$0.92 | +10.0% | Beat |
| Jun 30, 2025 | Q2 2025 | -$1.04 | -$0.98 | +5.6% | Beat |
| Mar 31, 2025 | Q1 2025 | -$1.31 | -$1.10 | +15.9% | Beat |
Track NTLA with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for NTLA and your entire portfolio.